High-fat-diet-induced obesity causes an inflammatory and tumor-promoting microenvironment in the rat kidney

DMM Disease Models and Mechanisms

Volumn 5, Issue 5, 2012, Pages 627-635

  Stemmer, Kerstin ^a,b   Perez Tilve, Diego ^a   Ananthakrishnan, Gayathri ^a   Bort, Anja ^a,c   Seeley, Randy J ^a   Tschöp, Matthias H ^b   Dietrich, Daniel R ^c   Pfluger, Paul T ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LEPTIN RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; MONOCYTE CHEMOTACTIC PROTEIN 1; STAT3 PROTEIN; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CHEMISTRY; CARCINOGENESIS; CELL GROWTH; CELL INFILTRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE SEVERITY; FATTY ACID BLOOD LEVEL; KIDNEY CANCER; KIDNEY DISEASE; KIDNEY TUBULE; LIPID DIET; LIPOTOXICITY; MALE; MONOCYTE; NEPHRITIS; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; TUMOR MICROENVIRONMENT; TUMOR PROMOTION; WEIGHT GAIN;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DIET, HIGH-FAT; HORMONES; INFLAMMATION; KIDNEY; KIDNEY NEOPLASMS; LIPIDS; MALE; OBESITY; PHOSPHORYLATION; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TOR SERINE-THREONINE KINASES; TUMOR MICROENVIRONMENT; WEIGHT GAIN;

MAMMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 84865486198     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.009407     Document Type: Article

References (50)

1. Aguila, M. B. and Mandarim-De-Lacerda, C. A. (2003). Effects of chronic high fat diets on renal function and cortical structure in rats. Exp. Toxicol. Pathol. 55, 187-195. (Pubitemid 37309769)
2. Al Zaid Siddiquee, K. and Turkson, J. (2008). STAT3 as a target for inducing apoptosis in solid and hematological tumors. Cell Res. 18, 254-267. (Pubitemid 351206162)
3. Altunkaynak, M. E., Ozbek, E., Altunkaynak, B. Z., Can, I., Unal, D. and Unal, B. (2008). The effects of high-fat diet on the renal structure and morphometric parametric of kidneys in rats. J. Anat. 212, 845-852. (Pubitemid 351772664)
4. Barnes, D. E. and Yaffe, K. (2011). The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 10, 819-828.
5. Baumann, H., Morella, K. K., White, D. W., Dembski, M., Bailon, P. S., Kim, H., Lai, C. F. and Tartaglia, L. A. (1996). The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc. Natl. Acad. Sci. USA 93, 8374-8378. (Pubitemid 26269565)
6. Bobulescu, I. A., Dubree, M., Zhang, J., McLeroy, P. and Moe, O. W. (2009). Reduction of renal triglyceride accumulation: effects on proximal tubule Na+/H+ exchange and urinary acidification. Am. J. Physiol.-Renal. 297, F1419-F1426.
7. Brunt, E. M. (2010). Pathology of nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 7, 195-203.
8. Calle, E. E., Rodriguez, C., Walker-Thurmond, K. and Thun, M. J. (2003). Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348, 1625-1638. (Pubitemid 36459468)
9. Cohen, S. M. and Ellwein, L. B. (1991). Genetic errors, cell proliferation, and carcinogenesis. Cancer Res. 51, 6493-6505.
10. Coimbra, T. M., Janssen, U., Grone, H. J., Ostendorf, T., Kunter, U., Schmidt, H., Brabant, G. and Floege, J. (2000). Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int. 57, 167-182. (Pubitemid 30227764)
11. Costes, V., Liautard, J., Picot, M. C., Robert, M., Lequeux, N., Brochier, J., Baldet, P. and Rossi, J. F. (1997). Expression of the interleukin 6 receptor in primary renal cell carcinoma. J. Clin. Pathol. 50, 835-840. (Pubitemid 27475791)
12. Dann, S. G., Selvaraj, A. and Thomas, G. (2007). mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. Trends Mol. Med. 13, 252-259. (Pubitemid 46836871)
13. Dietrich, D. R. and Swenberg, J. A. (1991). Preneoplastic lesions in rodent kidney induced spontaneously or by non-genotoxic agents: predictive nature and comparison to lesions induced by genotoxic carcinogens. Mutat. Res. 248, 239-260.
14. Elmarakby, A. A. and Imig, J. D. (2010). Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats. Clin. Sci. 118, 291-301.
15. Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N. et al. (2011). National, regional, and global trends in body-mass index since 1980, systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 377, 557-567.
16. Frayn, K. N. and Maycock, P. F. (1980). Skeletal muscle triacylglycerol in the rat: methods for sampling and measurement, and studies of biological variability. J. Lipid Res. 21, 139-144. (Pubitemid 10120447)
17. Gregor, M. F. and Hotamisligil, G. S. (2011). Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 29, 415-445.
18. Grivennikov, S. I. and Karin, M. (2011). Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage. Ann. Rheum. Dis. 70 Suppl. 1, i104-i108.
19. Grivennikov, S. I., Greten, F. R. and Karin, M. (2010). Immunity, inflammation, and cancer. Cell 140, 883-899.
20. Guo, C., Yang, G., Khun, K., Kong, X., Levy, D., Lee, P. and Melamed, J. (2009). Activation of Stat3 in renal tumors. Am. J. Transl. Res. 1, 283-290.
21. Hanahan, D. and Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674.
22. Hao, J., Liu, S. X., Zhao, S., Liu, Q. J., Liu, W. and Duan, H. J. (2012). High-fat diet causes increased serum insulin and glucose which synergistically lead to renal tubular lipid deposition and extracellular matrix accumulation. Br. J. Nutr. 107, 74-85.
23. Hard, G. C., Alden, C. L., Stula, E. F. and Trump, B. F. (1995). Proliferative lesions of the kidney in the rat. In Guides for Toxicologic Pathology, pp. 1-19. Washington: STP/ARP/AFIP.
24. Haslam, D. W. and James, W. P. (2005). Obesity. Lancet 366, 1197-1209. (Pubitemid 41393598)
25. Horiguchi, A., Oya, M., Shimada, T., Uchida, A., Marumo, K. and Murai, M. (2002). Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome. J. Urol. 168, 762-765. (Pubitemid 34793359)
26. Horiguchi, A., Sumitomo, M., Asakuma, J., Asano, T., Zheng, R., Nanus, D. M. and Hayakawa, M. (2006). Increased serum leptin levels and over expression of leptin receptors are associated with the invasion and progression of renal cell carcinoma. J. Urol. 176, 1631-1635. (Pubitemid 44307222)
27. Horiguchi, A., Asano, T., Kuroda, K., Sato, A., Asakuma, J., Ito, K., Hayakawa, M. and Sumitomo, M. (2010). STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma. Br. J. Cancer 102, 1592-1599.
28. Jeong, Y. J., Bong, J. G., Park, S. H., Choi, J. H. and Oh, H. K. (2011). Expression of leptin, leptin receptor, adiponectin, and adiponectin receptor in ductal carcinoma in situ and invasive breast cancer. J. Breast Cancer 14, 96-103.
29. Jiang, T., Wang, Z., Proctor, G., Moskowitz, S., Liebman, S. E., Rogers, T., Lucia, M. S., Li, J. and Levi, M. (2005). Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J. Biol. Chem. 280, 32317-32325. (Pubitemid 41361841)
30. Kume, S., Uzu, T., Araki, S., Sugimoto, T., Isshiki, K., Chin-Kanasaki, M., Sakaguchi, M., Kubota, N., Terauchi, Y., Kadowaki, T. et al. (2007). Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet. J. Am. Soc. Nephrol. 18, 2715-2723. (Pubitemid 47531198)
31. Kuraishy, A., Karin, M. and Grivennikov, S. I. (2011). Tumor promotion via injury- and death-induced inflammation. Immunity 35, 467-477.
32. Lee, D. F. and Hung, M. C. (2007). All roads lead to mTOR: integrating inflammation and tumor angiogenesis. Cell Cycle 6, 3011-3014.
33. Levin, B. E., Dunn-Meynell, A. A., Balkan, B. and Keesey, R. E. (1997). Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats. Am. J. Physiol. 273, R725-R730.
34. Maya-Monteiro, C. M. and Bozza, P. T. (2008). Leptin and mTOR: partners in metabolism and inflammation. Cell Cycle 7, 1713-1717. (Pubitemid 351988736)
35. Nogueiras, R., Wiedmer, P., Perez-Tilve, D., Veyrat-Durebex, C., Keogh, J. M., Sutton, G. M., Pfluger, P. T., Castaneda, T. R., Neschen, S., Hofmann, S. M. et al. (2007). The central melanocortin system directly controls peripheral lipid metabolism. J. Clin. Invest. 117, 3475-3488. (Pubitemid 350097003)
36. Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B. and Ludwig, D. S. (2005). A potential decline in life expectancy in the United States in the 21st century. N. Engl. J. Med. 352, 1138-1145. (Pubitemid 40365358)
37. Park, E. J., Lee, J. H., Yu, G. Y., He, G., Ali, S. R., Holzer, R. G., Osterreicher, C. H., Takahashi, H. and Karin, M. (2010). Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140, 197-208.
38. Perez-Tilve, D., Hofmann, S. M., Basford, J., Nogueiras, R., Pfluger, P. T., Patterson, J. T., Grant, E., Wilson-Perez, H. E., Granholm, N. A., Arnold, M. et al. (2010). Melanocortin signaling in the CNS directly regulates circulating cholesterol. Nat. Neurosci. 13, 877-882.
39. Renehan, A. G., Tyson, M., Egger, M., Heller, R. F. and Zwahlen, M. (2008). Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371, 569-578. (Pubitemid 351232031)
40. Rothwell, N. J., Saville, M. E. and Stock, M. J. (1982). Effects of feeding a "cafeteria"diet on energy balance and diet-induced thermogenesis in four strains of rat. J. Nutr. 112, 1515-1524. (Pubitemid 13238145)
41. Stachowicz, M., Mazurek, U., Nowakowska-Zajdel, E., Niedworok, E., Fatyga, E. and Muc-Wierzgon, M. (2010). Leptin and its receptors in obese patients with colorectal cancer. J. Biol. Regul. Homeost. Agents 24, 287-295.
42. Stemmer, K., Ellinger-Ziegelbauer, H., Ahr, H. J. and Dietrich, D. R. (2007). Carcinogen-specific gene expression profiles in short-term treated Eker and wild-type rats indicative of pathways involved in renal tumorigenesis. Cancer Res. 67, 4052-4068. (Pubitemid 46815050)
43. Stemmer, K., Ellinger-Ziegelbauer, H., Ahr, H. J. and Dietrich, D. R. (2009). Molecular characterization of preneoplastic lesions provides insight on the development of renal tumors. Am. J. Pathol. 175, 1686-1698.
44. Tedla, F. M., Brar, A., Browne, R. and Brown, C. (2011). Hypertension in chronic kidney disease: navigating the evidence. Int. J. Hypertens. 2011, 132405.
45. Unger, R. H., Clark, G. O., Scherer, P. E. and Orci, L. (2010). Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim. Biophys. Acta 1801, 209-214.
46. Vaisse, C., Halaas, J. L., Horvath, C. M., Darnell, J. E., Jr, Stoffel, M. and Friedman, J. M. (1996). Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice. Nat. Genet. 14, 95-97. (Pubitemid 26301554)
47. Villanueva, E. C. and Myers, M. G., Jr (2008). Leptin receptor signaling and the regulation of mammalian physiology. Int. J. Obes. 32 Suppl. 7, S8-S12.
48. Wang, Z., Jiang, T., Li, J., Proctor, G., McManaman, J. L., Lucia, S., Chua, S. and Levi, M. (2005). Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes. Diabetes 54, 2328-2335. (Pubitemid 41134259)
49. Xin, H., Zhang, C., Herrmann, A., Du, Y., Figlin, R. and Yu, H. (2009). Sunitinib inhibition of Stat3 induces renal cell carcinoma tumor cell apoptosis and reduces immunosuppressive cells. Cancer Res. 69, 2506-2513.
50. Yu, H., Pardoll, D. and Jove, R. (2009). STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer 9, 798-809.